CareDx (CDNA) Tops Q1 EPS by 21c; Withdraws Guidance

CareDx (NASDAQ: CDNA) reported Q1 EPS of ($0.11), $0.21 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $77.26 million versus the consensus estimate of $80.7 million.

GUIDANCE:

CareDx is withdrawing 2023 revenue guidance at this time given a multitude of unknown variables related to the March and May 2023 Billing Article revisions.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance